Literature DB >> 8267567

Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus.

H Tsukaguchi1, H Matsubara, S Aritaki, T Kimura, S Abe, M Inada.   

Abstract

Nephrogenic diabetes insipidus (NDI) is a rare X-linked disorder exhibiting renal resistance to the antidiuretic action of arginine vasopressin (AVP). Recent elucidation of the vasopressin V2 (renal type) receptor gene structure has enabled us to test the hypothesis that the genetic defect in the V2 receptor is the likely molecular basis of NDI. By using the polymerase chain reaction (PCR)-direct sequencing, we identified novel V2 receptor gene mutations in two unrelated Japanese kindreds with NDI. In the male patients of kindred A, a single codon deletion in one of two consecutive GTC triplets (nucleotide 832 to 837) was detected. This base change resulted in the loss of a valine residue in the 6th transmembrane domain. In the affected males of kindred B, a G to C substitution was found at nucleotide 428, altering codon 143 from arginine (CGT) to proline (CCT) in the second cytoplasmic domain. PCR-single strand conformation polymorphism (SSCP) analysis of family members demonstrated that the mutations cosegregated with clinically affected individuals and were absent in normal subjects. Our results suggest that different V2 receptor defects could be responsible for AVP resistance in individual NDI kindreds.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267567     DOI: 10.1006/bbrc.1993.2578

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Molecular Architecture of G Protein-Coupled Receptors.

Authors:  A Michiel van Rhee; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  1996-01-01       Impact factor: 4.360

2.  Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

Authors:  D G Bichet; M Birnbaumer; M Lonergan; M F Arthus; W Rosenthal; P Goodyer; H Nivet; S Benoit; P Giampietro; S Simonetti
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

3.  Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide.

Authors:  T Schoneberg; J Yun; D Wenkert; J Wess
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

4.  Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.

Authors:  H Tsukaguchi; H Matsubara; S Taketani; Y Mori; T Seido; M Inada
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

5.  A novel mutation of the arginine vasopressin receptor 2 gene in a patient with congenital nephrogenic diabetes insipidus.

Authors:  Asako Tajima; Ichiro Miyata; Akira Katayama; Shigeru Toyoda; Yoshikatsu Eto
Journal:  Clin Pediatr Endocrinol       Date:  2005-02-14

6.  Valine-279 Deletion-Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis.

Authors:  Ming-Chun Chen; Yu-Chao Hsiao; Chun-Chun Chang; Sheng-Feng Pan; Chih-Wen Peng; Ya-Tzu Li; Cheng-Der Liu; Je-Wen Liou; Hao-Jen Hsu
Journal:  Biomedicines       Date:  2021-03-15

7.  Congenital nephrogenic diabetes insipidus presenting as osmotic demyelination syndrome in infancy: A case report.

Authors:  Satoru Kobayashi; Nana Mizuno; Kyoko Yokoi; Takayasu Mori; Eisei Sohara; Shinichi Uchida
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.